Signs and symptoms of ocular surface disease in patients on topical intraocular pressure-lowering therapy

Related authors

• Beatriz Gomes
• Paulo Romeu de Freitas Turiel
• Fabiane Pereira Marques
• Fernanda Pessoa Bernardo
• Marcus Vinicius Abbud Safady
• André Luís Freire Portes
• Marcony Rodrigues Santhiago

Related articles

• Use of machine learning to predict the risk of early morning intraocular pressure peaks in glaucoma patients and suspects
• Glaucoma suspects referred by general ophthalmologists to a tertiary center in Brazil: outcomes of the glaucoma specialist assessment
• Eye diseases associated with psoriatic arthritis in the Amazon
• TXNRD2 (rs35934224) CT genotype as possible protective marker for primary open-angle glaucoma in a Brazilian population
• Outcomes and success predictors of micropulse transscleral cyclophotocoagulation in patients with refractory glaucoma
• Phacoemulsification with Kahook Dual Blade goniotomy in eyes with medically treated glaucoma: analysis of surgical outcomes and success predictors
• Intraocular pressure changes under an atmospheric pressure spectrum in a multiplace hyperbaric chamber
• Repeat selective laser trabeculoplasty in glaucoma and ocular hypertension: a review of efficacy and safety
• Aqueous humor renin, angiotensin I, and angiotensin II activity in primary open-angle glaucoma
• Assessment of short-term intraocular pressure parameters in phakic and pseudophakic patients with primary open-angle glaucoma

Click here to search